NCT02228694View on ClinicalTrials.gov

The IMPROVE Study-IMPact of a Regulated ADC System

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Medication Administered in ErrorMedication Compliance
Trial Locations (1)

07601

Hackensack University Medical center, Hackensack

Sponsors

Collaborators (1)

Omnicell
All Listed Sponsors
collaborator

Omnicell

INDUSTRY

lead

Hackensack Meridian Health

OTHER

NCT02228694 - The IMPROVE Study-IMPact of a Regulated ADC System | Biotech Hunter | Biotech Hunter